Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

VRP

Verona Pharma (VRP)

Verona Pharma Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:VRP
DateTimeSourceHeadlineSymbolCompany
02/02/20216:17AMUK RegulatoryVerona Pharma plc Correcting And Replacing -- Verona Pharma Reports Positive Phase 2 Results With Pmdi Formulation Of Ensifen...LSE:VRPVerona Pharma Plc
02/02/20212:00AMUK RegulatoryVerona Pharma plc Verona Pharma Reports Positive Phase 2 Results With Pmdi Formulation Of Ensifentrine In CopdLSE:VRPVerona Pharma Plc
01/14/20212:00AMUK RegulatoryVerona Pharma plc Verona Pharma Completes Enrollment In Pilot Study Of Pmdi Ensifentrine In U.S. Patients Hospitalized With C...LSE:VRPVerona Pharma Plc
01/05/20212:00AMUK RegulatoryVerona Pharma plc Verona Pharma To Present At H.C. Wainwright Virtualbioconnect ConferenceLSE:VRPVerona Pharma Plc
11/23/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma Secures Up To $30 Million Debt Financing From Silicon Valley BankLSE:VRPVerona Pharma Plc
11/09/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma Announces November 2020 Virtual Investor Conference ParticipationLSE:VRPVerona Pharma Plc
10/30/20203:00AMUK RegulatoryAIM Cancellation - Verona Pharma PLCLSE:VRPVerona Pharma Plc
10/29/20203:09PMAlliance NewsAlliance NewsIN BRIEF: Verona Pharma Says Third Quarter Loss WidensLSE:VRPVerona Pharma Plc
10/29/20203:00AMUK RegulatoryVerona Pharma plc Verona Pharma Plc Operational Update And Financial Results For The Three And Nine Months Ended September30,...LSE:VRPVerona Pharma Plc
10/28/20207:01AMUK RegulatoryVerona Pharma plc Verona Pharma Plc : Update On Aim DelistingLSE:VRPVerona Pharma Plc
10/23/202012:30PMUK RegulatoryFTSE Russell Verona PharmaLSE:VRPVerona Pharma Plc
10/22/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma To Announce Interim Results For The Three And Nine Months Ended September 30, 2020 And Provid...LSE:VRPVerona Pharma Plc
10/13/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma To Present Phase 2b Copd Symptom And Quality Of Life Data With Ensifentrine At Chest 2020LSE:VRPVerona Pharma Plc
09/23/20204:06AMUK RegulatoryVerona Pharma plc Verona Pharma Initiates Phase 3 Clinical Trials With Nebulized Ensifentrine For The Maintenance Treatment O...LSE:VRPVerona Pharma Plc
09/21/20209:12AMAlliance NewsAlliance NewsIN BRIEF: Verona Pharma To Delist From AIM But Remain On NasdaqLSE:VRPVerona Pharma Plc
09/21/20202:00AMUK RegulatoryVerona Pharma plc Intended Delisting And Cancellation Of Ordinary Shares From Trading On AimLSE:VRPVerona Pharma Plc
09/17/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma To Ring The Nasdaq Closing Bell To Celebrate $200 Million FinancingLSE:VRPVerona Pharma Plc
09/16/20208:25AMUK RegulatoryVerona Pharma plc Verona Pharma Announces Publication Of Phase 2b Copd Symptom Data In The International Journal Of Chronic O...LSE:VRPVerona Pharma Plc
09/08/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma Initiates Pilot Study With Pmdi Ensifentrine In U.S. Patients Hospitalized With Covid-19LSE:VRPVerona Pharma Plc
09/02/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma To Present At H.C. Wainwright 22nd Annual Global Virtual Investment ConferenceLSE:VRPVerona Pharma Plc
08/26/20205:19AMUK RegulatoryVerona Pharma plc Verona Pharma Plc: Grant Of Radsus And Pdmr DealingsLSE:VRPVerona Pharma Plc
08/24/20206:09AMAlliance NewsAlliance NewsVerona Pharma Says Study Shows Ensifentrine Improves Lung FunctionLSE:VRPVerona Pharma Plc
08/24/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma To Present Phase 2b Data With Ensifentrine In Copd At The European Respiratory Society Intern...LSE:VRPVerona Pharma Plc
08/19/20205:35AMAlliance NewsAlliance NewsVerona Pharma Makes Progress In Phase Two Of Inhaler Clinical TrialLSE:VRPVerona Pharma Plc
08/19/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma Initiates Multiple Dose Part Of Phase 2 Clinical Trial With Pmdi Formulation Of Ensifentrine ...LSE:VRPVerona Pharma Plc
08/14/20206:05AMUK RegulatoryVerona Pharma PLC Second Price Monitoring ExtnLSE:VRPVerona Pharma Plc
08/14/20206:00AMUK RegulatoryVerona Pharma PLC Price Monitoring ExtensionLSE:VRPVerona Pharma Plc
08/14/20204:22AMAlliance NewsAlliance NewsVerona To Trial Ensifentrine For Covid-19; First Half Loss WidensLSE:VRPVerona Pharma Plc
08/14/20202:00AMUK RegulatoryVerona Pharma plc Verona Pharma Plcoperational Update And Financial Results For The Three And Six Months Ended June30, 2020LSE:VRPVerona Pharma Plc
08/07/202010:46AMUK RegulatoryVerona Pharma plc Verona Pharma Plc: Tr-1: Standard Form For Notification Of Major HoldingsLSE:VRPVerona Pharma Plc
 Showing the most relevant articles for your search:LSE:VRP